Caryn Hashimoto

Adjuvant formulations possess differing efficacy in the potentiation of antibody and cell mediated responses to a human malaria vaccine under selective immune genes knockout environment

George Hui, Caryn Hashimoto · International Immunopharmacology · 2008 · 32 citations · Full text

Vaccination, Medicine, Vaccine Target +9

Plasmodium falciparum anti-MSP1-19 antibodies induced by MSP1-42 and MSP1-19 based vaccines differed in specificity and parasite growth inhibition in terms of recognition of conserved versus variant epitopes

George Hui, Caryn Hashimoto · Vaccine · 2006 · 26 citations

Vaccination, Anti-msp1-19 Antibodies, Vaccine Development +6

In Vivo Expression and Immunological Studies of the 42-Kilodalton Carboxyl-Terminal Processing Fragment of<i>Plasmodium falciparum</i>Merozoite Surface Protein 1 in the Baculovirus-Silkworm System

Alan Lap‐Yin Pang, Caryn Hashimoto, Leslie Q. Tam et al. · Infection and Immunity · 2002 · 22 citations · Full text

Protective Msp-1 42, Malaria, Immunology +18

The requirement of CD80, CD86, and ICAM-1 on the ability of adjuvant formulations to potentiate antibody responses to a Plasmodium falciparum blood-stage vaccine

George Hui, Caryn Hashimoto · Vaccine · 2007 · 19 citations · Full text

Vaccination, Vaccine Development, Medicine +10

Antigenicity and immunogenicity of the N-terminal 33-kDa processing fragment of the Plasmodium falciparum merozoite surface protein 1, MSP1: Implications for vaccine development

Don Yuen, Wai‐Hang Leung, Randy Chi Fai Cheung et al. · Vaccine · 2006 · 15 citations

Vaccine Development, Pathogenesis, Malaria +7